Cytoskeletal protein flightless (Flii) is elevated in chronic and acute human wounds and wound fluid: Neutralizing its activity in chronic but not acute wound fluid improves cellular proliferation

European Journal of Dermatology

Volumn 22, Issue 6, 2012, Pages 740-750

  Ruzehaji, Nadira ^a,b   Grose, Randall ^a   Krumbiegel, Doreen ^a   Zola, Heddy ^a   Dasari, Pallave ^a   Wallace, Hilary ^b   Stacey, Michael ^c   Fitridge, Robert ^b   Cowin, Allison J ^a,b  

^a CHILD HEALTH RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Antibodies; Chronic wound; Cytoskeleton; Flightless; Wound fluid

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD3 ANTIGEN; CYTOSKELETON PROTEIN; FLIGHTLESS I; HEMOSIDERIN; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

AGED; ARTICLE; CELL PROLIFERATION; CHRONIC WOUND; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; INHIBITION KINETICS; LEG ULCER; LYMPHOCYTE COUNT; MALE; MONOCYTE; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SKIN FIBROBLAST; UPREGULATION; WOUND FLUID; WOUND HEALING IMPAIRMENT;

ADULT; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIBODIES, NEUTRALIZING; CELL PROLIFERATION; CELLS, CULTURED; CHRONIC DISEASE; FEMALE; FIBROBLASTS; HUMANS; LEG ULCER; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; NEUTROPHILS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, IGG; SKIN; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84874830654     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2012.1878     Document Type: Article

References (37)

1. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet 2005; 366: 1719-1724.
2. Cameron AJ, Welborn TA, Zimmet PZ, et al. Overweight and obesity in Australia: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust 2003; 178: 427-432.
3. Macri L, Clark RA. Tissue engineering for cutaneous wounds: selecting the proper time and space for growth factors, cells and the extracellular matrix. Skin Pharmacol Physiol 2009; 22: 83-93.
4. Schultz GS, Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 2009; 17: 153-162.
5. Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF. Impaired wound healing. Clin Dermatol 2007; 25: 19-25.
6. Jacinto A, Martinez-Arias A, Martin P. Mechanisms of epithelial fusion and repair. Nature Cell Biol 2001; 3: E117-E123.
7. Sun HQ, Yamamoto M, Mejillano M, Yin HL. Gelsolin, a multifunctional actin regulatory protein. J Biol Chem 1999; 274: 33179-33182.
8. Kopecki Z, Arkell R, Powell BC, Cowin AJ. Flightless I regulates hemidesmosome formation and integrin-mediated cellular adhesion and migration during wound repair. J Inv Dermatol 2009; 129: 2031-245.
9. Adams DH, Strudwick XL, Kopecki Z, et al. Gender specific effects on the actin-remodelling protein Flightless I and TGF-beta1 contribute to impaired wound healing in aged skin. Int J Biochem Cell Biol 2008; 40: 1555-1569.
10. Kwiatkowski DJ. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr Opin Cell Biol 1999; 11: 103-108.
11. Campbell HD, Fountain S, McLennan IS, et al. Fliih, a gelsolinrelated cytoskeletal regulator essential for early mammalian embryonic development. Mol Cell Biol 2002; 22: 3518-3526.
12. Cowin AJ, Adams DH, Strudwick XL, et al. Flightless I deficiency enhances wound repair by increasing cell migration and proliferation. J Pathol 2007; 211: 572-581.
13. Adams DH, Ruzehaji N, Strudwick XL, et al. Attenuation of Flightless I, an actin-remodelling protein, improves burn injury repair via modulation of transforming growth factor (TGF)-beta1 and TGF-beta3. Brit J Dermatol 2009; 161: 326-336.
14. Kopecki Z, Cowin AJ. Flightless I: an actin-remodelling protein and an important negative regulator of wound repair. Int J Biochem Cell Biol 2008; 40: 1415-1419.
15. Claudianos C, Campbell HD. The novel flightless-I gene brings together two gene families, actin-binding proteins related to gelsolin and leucine-rich-repeat proteins involved in Ras signal transduction. Mol Biol Evol 1995; 12: 405-414.
16. Davy DA, Campbell HD, Fountain S, de Jong D, Crouch MF. The flightless I protein colocalizes with actin-and microtubule-based structures in motile Swiss 3T3 fibroblasts: evidence for the involvement of PI 3-kinase and Ras-related small GTPases. J Cell Sci 2001; 114: 549-562.
17. Lee YH, Campbell HD, Stallcup MR. Developmentally essential protein flightless I is a nuclear receptor coactivator with actin binding activity. Mol Cell Biol 2004; 24: 2103-2117.
18. Wang T, Chuang TH, Ronni T, et al. Flightless I homolog negatively modulates the TLR pathway. J Immunol 2006; 176: 1355-1362.
19. Hayashi T, Funato Y, Terabayashi T, et al. Nucleoredoxin negatively regulates Toll-like receptor 4 signaling via recruitment of flightless-I to myeloid differentiation primary response gene (88). J Biol Chem 285: 18586-18593.
20. Gruhler A, Olsen JV, Mohammed JV, et al. Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway. Mol Cell Proteomics 2005; 4: 310-327.
21. Cowin AJ, Adams D, Geary SM, et al. Wound healing is defective in mice lacking tetraspanin CD151. J Inv Dermatol 2006; 126: 680-689.
22. Harding KG, Moore K, Phillips TJ. Wound chronicity and fibroblast senescence-implications for treatment. Int Wound J 2005; 2: 364-368.
23. Trengove NJ, Stacey MC, MacAuley S, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999; 7: 442-452.
24. Cowin AJ, Hatzirodos N, Rigden J, Fitridge R, Belford DA. Etanercept decreases tumor necrosis factor-alpha activity in chronic wound fluid. Wound Repair Regen 2006; 14: 421-426.
25. Lei N, Franken L, Ruzehaji N, Offenhäuser C, Cowin AJ, Murray RZ. Flightless, secreted through a late endosome/lysosome pathway, binds LPS and dampens cytokine secretion. J Cell Sci 2012.
26. Lee WM, Galbraith RM. The extracellular actin-scavenger system and actin toxicity. N Engl J Med 1992; 326: 1335-1341.
27. Dahl B, Schiødt FV, Ott P, Gvozdenovic R, Yin HL, Lee WM. Plasma gelsolin is reduced in trauma patients. Shock 1999; 12: 102-104.
28. Grinnell F, Baxter CR, Zhu M, Yin HL. Detection of the actin scavenger system in burn wound fluid. Wound Repair Regen 1993; 1: 236-243.
29. McDonald B, Pittman K, Menezes GB, et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010; 330: 362-366.
30. Feng Y, Santoriello C, Mione M, Hurlstone A, Martin P. Live imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammation. PLoS Biol 2010; 8: e1000562.
31. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008; 8: 279-289.
32. Segal AW. How neutrophils kill microbes. Annu Rev Immunol 2005; 23: 197-223.
33. Lundqvist K, Sorensen OE, Schmidtchen A. Increased levels of human neutrophil alpha-defensins in chronic venous leg ulcers. J Dermatol Sci 2008; 51: 131-134.
34. Peral MC, Rachid MM, Gobbato NM, Huaman Martinez MA, Valdez JC. Interleukin-8 production by polymorphonuclear leukocytes from patients with chronic infected leg ulcers treated with Lactobacillus plantarum. Clin Microbiol Infect 2010; 16: 281-286.
35. Dai P, Jeong SY, Yu Y, et al. Modulation of TLR signaling by multiple MyD88-interacting partners including leucine-rich repeat Fli-I-interacting proteins. J Immunol 2009; 182: 3450-3460.
36. Pukstad BS, Ryan L, Flo TH, et al. Non-healing is associated with persistent stimulation of the innate immune response in chronic venous leg ulcers. J Dermatol Sci 2010; 59: 115-122.
37. Bermudez DM, Xu J, Herdrich BJ, Radu A, Mitchell ME, Liechty KW. Inhibition of stromal cell-derived factor-1alpha further impairs diabetic wound healing. J Vasc Surg 2011; 53: 774-784.